A Japan-based pharmaceutical company focused on developing and commercializing prescription medicines, with a strategic emphasis on oncology and antibody-drug conjugate (ADC) therapies. Its drug pipeline and partnerships—most notably with AstraZeneca on cancer treatments such as Enhertu—have made it...
3 members of Congress have disclosed 3 trades in Daiichi Sankyo Company, Limited (DSNKY), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-07-01 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $50K – $100K |
| 2019-04-04 | David P. Roe | buy | $1K – $15K |